本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

爵士制药

100.34
-2.4400-2.37%
盘后99.89-0.4500-0.45%19:22 EDT
成交量:61.08万
成交额:6,114.46万
市值:60.94亿
市盈率:11.60
高:102.48
开:102.11
低:98.96
收:102.78
数据加载中...

公司资料

公司名字:
爵士制药
交易所:
NASDAQ
成立时间:
2003
员工人数:
2800
公司地址:
Waterloo Exchange,Fifth Floor,Waterloo Road,Dublin 4,Dublin,Co. Dublin,Ireland
邮编:
D04 E5W7
传真:
- -
简介:
Jazz Pharmaceuticals Public Limited Company是一家公众有限责任公司,根据爱尔兰法律于2005年3月成立。爵士制药公司是一家专业制药公司,专注于医药产品的识别、开发和商业化,以满足巨大的医疗需求。 自2003年建立以来,它已经建立了一个商业和发展组织,组装的产品和候选产品目前包括两种在售产品,以及正处在临床开发的各个阶段的候选产品。它目前销售两种产品: Xyrem (羟丁酸钠) ,这是经美国食品和药物管理局(FDA)唯一批准的治疗嗜睡引起的猝倒证和白天过度嗜睡的产品;兰释CR (马来酸氟伏沙明)用于强迫症的治疗。公司通过其经验丰富的专业销售队伍:睡眠专家、神经病学家、肺科和精神科医生促进这些产品在美国销售。

董事

名称
职位
Bruce C. Cozadd
Chairperson and Chief Executive Officer
Anne O'Riordan
Independent Director
Catherine A. Sohn
Independent Director
Heather Ann McSharry
Independent Director
Jennifer E. Cook
Independent Director
Kenneth W. O'Keefe
Independent Director
Mark D. Smith
Independent Director
Norbert G. Riedel
Independent Director
Patrick G. Enright
Independent Director
Peter Gray
Independent Director
Rick E Winningham
Lead Independent Director
Seamus C. Mulligan
Independent Director

股东

名称
职位
Bruce C. Cozadd
Chairperson and Chief Executive Officer
Daniel N. Swisher, Jr.
President, Chief Operating Officer
Finbar Larkin
Senior Vice President, Technical Operations
Patricia Carr
Senior Vice President, Chief Accounting Officer
Renee Gala
Executive Vice President and Chief Financial Officer
Samantha Pearce
Senior Vice President, Europe and International
Kim Sablich
Executive Vice President and General Manager, US
Neena M. Patil
Executive Vice President and Chief Legal Officer
Robert Iannone
Executive Vice President, Global Head of Research and Development